From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2010
Last Reported 2010
Negated 1
Speculated 0
Reported most in Abstract
Documents 1
Total Number 1
Disease Relevance 0.87
Pain Relevance 0.94

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (Ccdc80) proteinaceous extracellular matrix (Ccdc80) extracellular matrix organization (Ccdc80)
Ccdc80 (Mus musculus)
Pain Link Frequency Relevance Heat
Antihyperalgesic 3 100.00 Very High Very High Very High
antagonist 3 99.58 Very High Very High Very High
cytokine 2 95.28 Very High Very High Very High
Hyperalgesia 3 93.92 High High
Endocannabinoid 1 82.00 Quite High
Cannabinoid receptor 3 79.84 Quite High
Inflammation 5 78.00 Quite High
IPN 4 75.00 Quite High
Central nervous system 1 58.24 Quite High
analgesia 1 56.92 Quite High
Disease Link Frequency Relevance Heat
Hyperalgesia 3 93.92 High High
Cancer 1 92.72 High High
Pressure And Volume Under Development 3 92.40 High High
Necrosis 1 92.24 High High
INFLAMMATION 1 78.00 Quite High
Inflammatory Pain 4 75.00 Quite High
Targeted Disruption 1 63.64 Quite High
Pain 1 37.80 Quite Low
Syndrome 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
However, the transient receptor potential vanilloid type 1 antagonist capsazepine did not affect either the antihyperalgesic or antiedematous effects of URB597.
Neg (not) Regulation (affect) of URB597 associated with antihyperalgesic and antagonist
1) Confidence 0.01 Published 2010 Journal J. Pharmacol. Exp. Ther. Section Abstract Doc Link 20375198 Disease Relevance 0.87 Pain Relevance 0.94

General Comments

This test has worked.

Personal tools